High potency and water dispersible Boswellia extract reduces pain and inflammation in subjects with osteoarthritis of the knee: A randomized, double-blind, placebo-controlled trial.

In 30 seconds

This randomized, double-blind, placebo-controlled trial evaluated the effects of a high potency Boswellia extract (OLNP-27) on knee osteoarthritis in 60 subjects aged 40 to 75. The study found that OLNP-27 significantly reduced total WOMAC scores and pain, stiffness, and visual analogue scores compared to placebo, with effects observable as early as 7 days.

Key findings

• OLNP-27 reduced total WOMAC score significantly compared to placebo.
• Pain and stiffness scores decreased significantly after 7 days of OLNP-27 supplementation.
• High-sensitivity-CRP levels were significantly lower in the OLNP-27 group than in the placebo group.

Why it matters

The findings suggest that Boswellia extract may offer a natural and effective option for managing knee osteoarthritis symptoms, potentially providing an alternative to conventional treatments.